Oncobiologics, Inc. [________] Shares1 Common Stock ($0.01 par value) Underwriting AgreementOncobiologics, Inc. • April 27th, 2016 • Biological products, (no disgnostic substances) • New York
EXECUTIVE Employment AgreementExecutive Employment Agreement • April 27th, 2016 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New Jersey
This Executive Employment Agreement dated as of February 24, 2016 (“Agreement”) is by and between Elizabeth A. Yamashita (“Executive”) and Oncobiologics, Inc. (“Company”).
INVESTORS’ RIGHTS AGREEMENT by and among ONCOBIOLOGICS, INC., STRIDES PHARMA INC. and CERTAIN KEY HOLDERS March 10, 2014Investors’ Rights Agreement • April 27th, 2016 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New York
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 10th day of March, 2014, by and among Oncobiologics, Inc., a New Jersey corporation (the “Company”), Strides Pharma Inc., a company incorporated under the laws of New Jersey (the “Investor”), and each of the shareholders listed on Schedule A hereto, each of whom is referred to herein as a “Key Holder”.
ContractOncobiologics, Inc. • April 27th, 2016 • Biological products, (no disgnostic substances) • New York
NEITHER THIS WARRANT, NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”), HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE OFFERED, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES OR BLUE SKY LAWS, PURSUANT TO REGISTRATION OR QUALIFICATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE COMPANY MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY TO THE EFFECT THAT ANY PROPOSED TRANSFER IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES OR BLUE SKY LAWS. THIS WARRANT IS SUBJECT TO THE TRANSFER RESTRICTIONS SET FORT
Amended and Restated Performance Stock Unit AgreementPerformance Stock Unit Agreement • April 27th, 2016 • Oncobiologics, Inc. • Biological products, (no disgnostic substances) • New Jersey
THIS AMENDED AND RESTATED PERFORMANCE STOCK UNIT AGREEMENT (the “Amended and Restated Agreement”), dated as of _________________ (the “Effective Date”), is between Oncobiologics, Inc., a Delaware corporation (the “Company”), and _____________________________ (the “Participant”).
